AR030651A1 - Antibacterianos - Google Patents

Antibacterianos

Info

Publication number
AR030651A1
AR030651A1 ARP010104289A ARP010104289A AR030651A1 AR 030651 A1 AR030651 A1 AR 030651A1 AR P010104289 A ARP010104289 A AR P010104289A AR P010104289 A ARP010104289 A AR P010104289A AR 030651 A1 AR030651 A1 AR 030651A1
Authority
AR
Argentina
Prior art keywords
attached
hydrogen
alkyl
oxygen
formula
Prior art date
Application number
ARP010104289A
Other languages
English (en)
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0022439A external-priority patent/GB0022439D0/en
Priority claimed from GB0022440A external-priority patent/GB0022440D0/en
Priority claimed from GB0024674A external-priority patent/GB0024674D0/en
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of AR030651A1 publication Critical patent/AR030651A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Un compuesto de formula (1) en donde R y R2, junto con el átomo de nitrogeno con el que están unidos, forman pirrolidinilo o piperidinilo, R1 es un grupo de formula (2): -C(=X)-R9; R3 y R3' son hidrogeno, deuterio, o halogeno, R4, R5 y R10 son independientemente unos de otros, hidrogeno o alquilo, R6, R7 y R8 son hidrogeno o deuterio; R9 es amino, alquilo, arilo, heterociclilo o mercapto; y si X es oxígeno, R9 es adicionalmente hidrogeno; R'10 es alquilo, X es azufre, oxígeno, NR10, o N+(R'10)2, Y es azufre u oxígeno y m es 0, 1, o 2; con la condicion de que, cuando R y R2, junto con el átomo de nitrogeno con el que estén unidos, formen piperidinilo, m es 0 , Y es S, e Y está unido en la posicion 3 del anillo de piperidina, ese grupo de la formula (1) que está unido al anillo de piperidina por medio del residuo Y está en la configuracion (S) o en la configuracion (R) de preferencia en la configuracion (S), el cual es por ejemplo, util como antimicrobiano y antibacteriano.
ARP010104289A 2000-09-13 2001-09-11 Antibacterianos AR030651A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0022439A GB0022439D0 (en) 2000-09-13 2000-09-13 Organic compounds
GB0022440A GB0022440D0 (en) 2000-09-13 2000-09-13 Organic Compounds
GB0024674A GB0024674D0 (en) 2000-10-09 2000-10-09 Organic compounds

Publications (1)

Publication Number Publication Date
AR030651A1 true AR030651A1 (es) 2003-08-27

Family

ID=27255885

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104289A AR030651A1 (es) 2000-09-13 2001-09-11 Antibacterianos

Country Status (17)

Country Link
US (3) US7169804B2 (es)
EP (1) EP1320525B1 (es)
JP (1) JP5134181B2 (es)
CN (1) CN1288134C (es)
AR (1) AR030651A1 (es)
AT (1) ATE264843T1 (es)
AU (1) AU2001291854A1 (es)
BR (1) BRPI0113837B8 (es)
CA (1) CA2418538C (es)
DE (1) DE60102936T2 (es)
ES (1) ES2220809T3 (es)
HK (1) HK1079506A1 (es)
MY (1) MY133930A (es)
PE (1) PE20020676A1 (es)
PT (1) PT1320525E (es)
TW (1) TWI306852B (es)
WO (1) WO2002022580A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
PL373460A1 (en) * 2002-07-24 2005-08-22 Sandoz Ag Pleuromutilin derivatives as antimicrobbials
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
US7544963B2 (en) * 2005-04-29 2009-06-09 Cree, Inc. Binary group III-nitride based high electron mobility transistors
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
WO2007037518A1 (ja) * 2005-09-29 2007-04-05 Dainippon Sumitomo Pharma Co., Ltd. ムチリン誘導体及びそれを含有する医薬組成物
EP1808431A1 (en) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
CA2654450A1 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
EP1908750A1 (en) 2006-10-05 2008-04-09 Nabriva Therapeutics Forschungs GmbH Process for the preparation of pleuromutilins
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
US20100184987A1 (en) * 2008-11-13 2010-07-22 Teva Pharmaceutical Industries Ltd. Preparation of Retapamulin via its Pleuromutilin-thiol precursor
CN103709115A (zh) * 2012-10-09 2014-04-09 山东亨利医药科技有限责任公司 截短侧耳素类抗生素衍生物
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
DE2811314A1 (de) 1978-03-16 1979-09-27 Sandoz Ag Kokzidiostatisches kombinationspraeparat
DE2966635D1 (en) 1979-01-12 1984-03-08 Sandoz Ag New pleuromutilin derivatives, their production and pharmaceutical compositions containing them
ZA80175B (en) * 1979-01-12 1981-08-26 Sandoz Ltd New pleuromutilin derivatives, their production and use
EP0153277B1 (de) 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
HUP9900973A3 (en) 1996-01-03 2000-04-28 Smithkline Beecham Plc Carbamoyloxy derivatives of mutiline with antibacterial activity, pharmaceutical compns. contg. them and process for preparing the said compds.
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2000027790A1 (en) 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
AU3036200A (en) 1998-12-18 2000-07-12 Smithkline Beecham Plc Mutilin 14-ester derivatives having antibacterial activity
GB9918037D0 (en) 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
PL373460A1 (en) * 2002-07-24 2005-08-22 Sandoz Ag Pleuromutilin derivatives as antimicrobbials

Also Published As

Publication number Publication date
CA2418538C (en) 2009-12-22
DE60102936T2 (de) 2005-03-24
US20040102482A1 (en) 2004-05-27
PE20020676A1 (es) 2002-08-27
DE60102936D1 (de) 2004-05-27
AU2001291854A1 (en) 2002-03-26
MY133930A (en) 2007-11-30
EP1320525A1 (en) 2003-06-25
ES2220809T3 (es) 2004-12-16
TWI306852B (en) 2009-03-01
US7169804B2 (en) 2007-01-30
HK1079506A1 (en) 2006-04-07
US20070135483A1 (en) 2007-06-14
PT1320525E (pt) 2004-09-30
JP2004509107A (ja) 2004-03-25
WO2002022580A1 (en) 2002-03-21
CN1288134C (zh) 2006-12-06
CN1633415A (zh) 2005-06-29
US20090209584A1 (en) 2009-08-20
EP1320525B1 (en) 2004-04-21
BRPI0113837B1 (pt) 2019-01-29
BRPI0113837B8 (pt) 2021-05-25
JP5134181B2 (ja) 2013-01-30
BR0113837A (pt) 2003-06-03
ATE264843T1 (de) 2004-05-15
US7569587B2 (en) 2009-08-04
CA2418538A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AR030651A1 (es) Antibacterianos
ES2120499T3 (es) Derivado de eritromicina.
CO5180568A1 (es) Compuestos farmaceuticos, especialmente mutilinas, composiciones farmaceuticas que los contienen
CR20120152A (es) Derivados de 3-aminopirrolidina como moduladores de receptores de quimocina
NL300374I2 (nl) Een pyrrolidythiocarbapenemderivaat met antibacteriële
PE106499A1 (es) Antagonistas del receptor ccr-3
CO6231035A2 (es) Novedoso compuesto heteromonociclico que tiene propiedades superiores como agente farmaceutico
AR055774A1 (es) Fenilacetamidas apropiadas como inhibidores de proteina quinasa
MEP8409A (en) Fused heterocyclic compound
HRP20070116A2 (en) Cyanopyrrolidine derivatives
NO20075650L (no) Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater
CO5650243A2 (es) Modulador del receptor canabinoide
CO6150147A2 (es) Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii
MX2009012380A (es) Compuestos de heteroarilamida pirimidona.
CO5700818A2 (es) Derivados de oxazol de tetraciclina
MX2009010823A (es) Compuesto de hidrazida y agente controlador de artropodos dañinos que contiene el mismo.
BR0312882A (pt) Derivados de pleuromutilina como antimicrobianos
SV2006002126A (es) Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica
PE20020996A1 (es) Antagonistas de ccr5 utiles para el tratamiento del sida
MX2010008362A (es) Derivados de heteroarilamida diazepinopirimidona sustituidos.
ES2124397T3 (es) Compuestos con heterociclos fusionados, que contienen nitrogeno.
MX2010008360A (es) Derivados de oxazepinopirimidona heteroarilamida sustituidos.
AR056285A1 (es) Derivados de triazolopirimidina y composiciones fungicidas
BR0308207A (pt) Derivado de arilamidina ou um sal do mesmo, composto, e, agente antifúngico
DE69328366T2 (de) Benzopyran und benzoxazin-derivate

Legal Events

Date Code Title Description
FA Abandonment or withdrawal